Your browser doesn't support javascript.
loading
FLOT (a chemotherapy regimen for gastric/esophagogastric junction cancer): to be treated as a highly emetogenic regimen or a moderately emetogenic one? Comparison of the emetogenic potential of FLOT versus FOLFOX and TAC regimens.
Ghorbani, Marziyeh; Dehghani, Mehdi; Fahimfar, Noushin; Namazi, Soha; Dehshahri, Ali.
Afiliação
  • Ghorbani M; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Dehghani M; Hematology Research Center, Department of Hematology and Medical Oncology, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Fahimfar N; Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Namazi S; Research Center for Rational Use of Drugs, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
  • Dehshahri A; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. A.Dehshahri@gmail.com.
Support Care Cancer ; 30(5): 3865-3873, 2022 May.
Article em En | MEDLINE | ID: mdl-35038031
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Vômito / Protocolos de Quimioterapia Combinada Antineoplásica / Antieméticos / Antineoplásicos Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Vômito / Protocolos de Quimioterapia Combinada Antineoplásica / Antieméticos / Antineoplásicos Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article